Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

A new study diagnosing infection in patients with pancreatic fluid collections may swiftly and accurately rule out active infection in the body.

6 Aug 2014

New less expensive method to enrich stable isotopes

Researchers at The University of Texas at Austin have devised a new method for enriching a group of the world's most expensive chemical commodities, stable isotopes, which are vital to medical imaging and nuclear power, as reported this week in the journal Nature Physics. For many isotopes, the new method is cheaper than existing methods. For others, it is more environmentally friendly.

30 Jun 2014

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators.

28 Jun 2014

Combination of MRI and PET imaging techniques can prevent second breast biopsy

Following a diagnosis of breast cancer, one of the hardest tasks is to distinguish the benign nodes in the breast from the malignant tumours, and this usually requires a tissue sample (biopsy) to be taken.

26 Jun 2014

Eden licenses Sandia’s technology to develop radioactive isotope for medical diagnostic tests

An Albuquerque startup company has licensed a Sandia National Laboratories technology that offers a way to make molybdenum-99, a key radioactive isotope needed for diagnostic imaging in nuclear medicine, in the United States.

18 Jun 2014

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment.

10 Jun 2014

Researchers reveal mysterious behavior of individual cells using radioluminescence microscopy

With a new molecular imaging system powerful enough to peer down to 20-micrometer resolution, researchers can now use radioluminescence to examine the characteristics of single, unconnected cells. The result is a fascinating picture of diversity among cells previously assumed to behave the same, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

10 Jun 2014

REM sleep disorder: A sign of impending neurodegenerative disease

How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

10 Jun 2014

Combined chemo and radionuclide therapy stops neuroendocrine tumors

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

10 Jun 2014

Late-life depression could become major risk factor for developing Alzheimer's

Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer's disease.

10 Jun 2014

Combination of novel molecular imaging techniques can help predict spread of cancer, patient survival

A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients' chances of survival, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

10 Jun 2014

Antibody-based molecular imaging agent offers hope for novel breast cancer treatments

For years researchers have been developing molecular imaging techniques that visualize hormonally active breast cancer cells-specifically those testing positive for human epidermal growth factor receptor 2 (HER2).

10 Jun 2014

Toshiba provides new PET/CT system for radiation and oncology imaging needs

Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba America Medical Systems, Inc.'s all-new Celesteion (pending 510(k) clearance).

9 Jun 2014

Actinium's Chairman to discuss role of alpha-particle radiopharmaceuticals at SNMMI Annual Meeting

Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium's alpha-particle radiopharmaceuticals in the treatment of leukemia patients.

9 Jun 2014

Congress supports full Medicare coverage of lung cancer screening for seniors

A large number of United States Senators and Representatives are taking the lead to support full Medicare coverage of low-dose computed tomography (LDCT) screening for seniors at high risk for lung cancer.

5 Jun 2014

Region Skåne and Sectra sign six-year agreement

Region Skåne, one of Sweden's largest care providers, has signed a six-year agreement with IT and medical technology company Sectra.

4 Jun 2014

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Medical Equipment Solutions and Applications, Europe's leader in multi-vendor service for Diagnostic Imaging systems, equipment and parts, and Heidelberg-based radiology management company Curagita are joining forces to bring new and broader solutions for a full range of Diagnostic Imaging services to the German healthcare market.

2 Jun 2014

Comer Children's Hospital offers high-dose radiation therapy for relapsed neuroblastoma

The University of Chicago Medicine Comer Children's Hospital has become the first in Illinois to offer pioneering, targeted, high-dose, intravenous radiation therapy for relapsed neuroblastoma and other difficult-to-treat cancers.

9 May 2014

Loyola offers patients the most advanced PET/CT scanner

Loyola University Medical Center is now offering patients the most advanced PET/CT scanner on the market. The state-of-the-art system is improving the diagnosis and treatment of cancer, heart disease, epilepsy, Alzheimer's disease and other conditions.

11 Apr 2014

Neuroinflammation levels higher in patients with chronic fatigue syndrome

Researchers at the RIKEN Center for Life Science Technologies, in collaboration with Osaka City University and Kansai University of Welfare Sciences, have used functional PET imaging to show that levels of neuroinflammation, or inflammation of the nervous system, are higher in patients with chronic fatigue syndrome than in healthy people.

4 Apr 2014

Nuclear Medicine News and Research

Further Reading

PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

New less expensive method to enrich stable isotopes

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Combination of MRI and PET imaging techniques can prevent second breast biopsy

Eden licenses Sandia’s technology to develop radioactive isotope for medical diagnostic tests

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Researchers reveal mysterious behavior of individual cells using radioluminescence microscopy

REM sleep disorder: A sign of impending neurodegenerative disease

Combined chemo and radionuclide therapy stops neuroendocrine tumors

Late-life depression could become major risk factor for developing Alzheimer's

Combination of novel molecular imaging techniques can help predict spread of cancer, patient survival

Antibody-based molecular imaging agent offers hope for novel breast cancer treatments

Toshiba provides new PET/CT system for radiation and oncology imaging needs

Actinium's Chairman to discuss role of alpha-particle radiopharmaceuticals at SNMMI Annual Meeting

Congress supports full Medicare coverage of lung cancer screening for seniors

Region Skåne and Sectra sign six-year agreement

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Comer Children's Hospital offers high-dose radiation therapy for relapsed neuroblastoma

Loyola offers patients the most advanced PET/CT scanner

Neuroinflammation levels higher in patients with chronic fatigue syndrome

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News